Biostax is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. Biostax has deep expertise and strong partnerships in the fields of autoimmunity and immune restoration and is able to deliver solutions today for people living with autoimmunity, chronic inflammation, infection, and cancer. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. Current efforts are focused in emerging markets where health challenges are prevalent, treatment expenses often limit availability for patients, and regulatory approval has already been granted. The company will also continue to pursue regulatory approval and commercialization initiatives in the U.S. and other international markets.
Biostax intends to advance select and efficient small-scale biotechnology, pharmaceutical and MedTech programs through subsidiaries, investment vehicles and partnerships utilizing a biotech portfolio hub-and-spoke business model.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 1317 Edgewater Dr.,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://biostaxcorp.com/
- HQ
- Orlando, FL
Biostax Corp. Questions
Biostax Corp.'s website is https://biostaxcorp.com/
Biostax Corp.'s LinkedIn profile is https://www.linkedin.com/company/biostaxcorp
Biostax Corp. has
5 employees.
View email and phone details for 5
employees at Biostax Corp..
Biostax Corp.'s industry is
Biotechnology Research
Biostax Corp.'s top competitors are
Cantai Therapeutics,
Empress Legal,
Statera Biopharma, Inc.,
Unikum Therapeutics,
Intellectual Property Consulting,
Aton Biotech,
Nanopharmaceutics, Inc.,
Tron Group Inc.,
Bayes Pllc,
Medler Ferro Woodhouse & Mills Pllc.
Biostax Corp.'s categories are Biotechnology Research
Biostax Corp.'s founding year is 2012
